SCHEDULE: HOLD Alapkezelo Zrt. Discloses 6.5% Stake in MediWound
Beneficial Ownership Disclosure
Hungarian investment fund HOLD Alapkezelo Zrt. has reported a 6.5% beneficial ownership stake in MediWound Ltd., holding 703,429 common shares.
Summary
- HOLD Alapkezelo Zrt., a Hungarian investment fund management company, has filed a Schedule 13G indicating beneficial ownership in MediWound Ltd.
- The reporting person, HOLD Alapkezelo Zrt., beneficially owns 703,429 common shares of MediWound Ltd.
- This ownership represents approximately 6.5% of MediWound Ltd.'s common stock, based on 10,793,057 shares outstanding as of December 31, 2024.
- HOLD Alapkezelo Zrt. holds sole voting power and sole dispositive power over all 703,429 shares.
- The shares were not acquired and are not held for the purpose or with the effect of changing or influencing the control of MediWound Ltd.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive due to the disclosure of a significant institutional stake, which can be interpreted as a vote of confidence. However, it is a factual ownership disclosure and does not contain operational or financial updates from the company itself.
Positives
- Increased institutional investor confidence in MediWound Ltd. as a significant stake is disclosed by HOLD Alapkezelo Zrt.
- The acquisition of a 6.5% stake by an investment fund may signal a positive long-term outlook from a professional investor.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding MediWound Ltd.'s future performance or operations.
Industry Context
The disclosure of a significant stake by an institutional investor like HOLD Alapkezelo Zrt. is a common occurrence in the public markets, reflecting ongoing portfolio adjustments and investment strategies. Such filings provide transparency into major ownership positions, which can influence market perception and liquidity for the issuer.
Stakeholder Impact
- Shareholders may view the increased institutional ownership as a positive signal, potentially leading to increased confidence and stability in the stock.
- The presence of a significant institutional investor could lead to greater scrutiny or engagement regarding corporate governance, although the filing explicitly states the shares are not held for control purposes.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date as of which 10,793,057 shares of MediWound's common stock were outstanding, used as the basis for percentage calculation. |
| 03/19/2025 | Date the 20F filing, which provided the shares outstanding figure, was filed. |
| 09/19/2025 | Signature date of the Schedule 13G filing by Daniel Moricz, Chief Investment Officer, Partner of HOLD Alapkezelo Zrt. |
| 09/22/2025 | Date of event which requires the filing of this statement. |
Recommendation
holdThe filing is a factual disclosure of beneficial ownership by an institutional investor and does not provide new operational, financial, or strategic information about MediWound Ltd. that would fundamentally alter an investment thesis. While increased institutional ownership can be a positive signal, it does not warrant a 'buy' or 'sell' recommendation based solely on this disclosure. Investors should 'hold' and continue to monitor the company's performance and future announcements.
Keywords
MediWound Ltd., HOLD Alapkezelo Zrt., Beneficial Ownership, Schedule 13G, Common Shares, Institutional Investment, Equity Stake, M68830104
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.